← Back to all trials
Active Not Recruiting
NCT07041125
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
Conditions: PFA Ablation and LAAC Procedures
Sex: All
Ages: 18 Years – N/A
Enrollment: 120
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Location: Arrhythmia Institute at Grandview Birmingham Alabama
Summary
This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
Eligibility Criteria
Inclusion Criteria: All inclusion criteria of the main DISRUPT-AF registry will apply. In addition, patients included in this sub study must meet the additional inclusion criteria below:
* Patients who are determined by physicians to be eligible for LAAC
* Patients whose LAAC with Watchman FLX Pro procedures are performed concomitant following AF ablation procedure
* Willing and able to provide additional informed consent to the sub-study (unless waiver of consent is obtained)
Exclusion Criteria: All exclusion criteria of the main DISRUPT-AF registry will apply. In addition, patients included in this sub study have the additional exclusion criteria below:
-Patients who are participating in other DISRUPT-AF sub-studies
Source: ClinicalTrials.gov (NCT07041125). StuddyBuddy aggregates publicly available trial information.